Suchergebnisse - "Fazio, Sergio"

PubPharm (473)

1

NOTCH3p.Arg1231Cys is Markedly Enriched in South Asians and Associated with Stroke

enthalten in: bioRxiv.org | 2024

von Rodriguez-Flores, J. | Khalid, S. | Parikshak, N. | +46

2

Comparison of Change in Lipoprotein(a) Mass and Molar Concentrations by Alirocumab and Risk of Subsequent Cardiovascular Events in ODYSSEY OUTCOMES

enthalten in: European journal of preventive cardiology | 2024

von Szarek, M. | Reijnders, E. | Steg, P. | +13

3

Low-Density Lipoprotein Cholesterol-Lowering Drugs : A Narrative Review

enthalten in: Journal of clinical medicine | 2024

von Ferri, N. | Ruscica, M. | Fazio, S. | +1

4

Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome : A Comparison of 3 Tests

enthalten in: Circulation | 2024

von Szarek, M. | Reijnders, E. | Jukema, J. | +15

5

Effect of PCSK9 inhibition on plasma levels of small dense low density lipoprotein-cholesterol and 7-ketocholesterol

enthalten in: Journal of clinical lipidology | 2024

von Mahmood, T. | Miles, J. | Minnier, J. | +4

6

Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association

enthalten in: Blood | 2023

von Chung, D. | Platten, K. | Ozawa, K. | +14

CommentIn: Blood. 2023 Sep 28;142(13):1110-1111. - PMID 37768693

7

Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events : A pooled, post hoc, competing risk analysis of alirocumab clinical trials

enthalten in: Cancer medicine | 2023

von Mohammadi, K. | Brackin, T. | Schwartz, G. | +6

8

Methods of inhibiting PCSK9

enthalten in: Europäisches Patentamt | 2023

von WU JIMMY | FAZIO SERGIO | TAVORI HAGAI

9

Serum cholesterol and the risk of developing hormonally driven cancers : A narrative review

enthalten in: Cancer medicine | 2023

von Murdock, D. | Sanchez, R. | Mohammadi, K. | +2

10

Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction : the ODYSSEY OUTCOMES trial

enthalten in: European heart journal | 2023

von Schwartz, G. | Szarek, M. | Bhatt, D. | +15

CommentIn: Eur Heart J. 2023 Apr 21;44(16):1418-1420. - PMID 36881636

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]